Description
1. Defining Treatment-Resistant Depression, Difficult to Treat Depression, and Staging Treatment Intensity 2. Clinical and Epidemiological Predictors of Treatment-Resistant Depression 3. The Economic Burden of Treatment-Resistant Depression: Cost-of-Illness Perspective 4. The Neurobiology of Treatment-Resistant Depression 5. Modelling Treatment-Resistant Depression in the Preclinical Setting 6. Treatment algorithms for Treatment-Resistant Depression 7. Tools to Aid Precision Treatments to Prevent or Manage Treatment-Resistant Depression: Pharmacogenomics, Machine Learning, and Artificial Intelligence 8. Tricyclic antidepressants for Treatment-Resistant Depression 9. Monoamine oxidase inhibitors for Treatment-Resistant Depression 10. Switching antidepressants in patients with Treatment-Resistant Depression 11. Adjunctive Strategies for Treatment-Resistant Depression 12. Combining antidepressants to address Treatment-Resistant Depression 13. Ketamine/Esketamine for Treatment-Resistant Depression 14. Psychedelic agents for Treatment-Resistant Depression 15. Inflammation and Treatment Resistance: Mechanisms and Treatment Implications 16. Opioid agents for Treatment-Resistant Depression 17. Transcranial magnetic stimulation for Treatment-Resistant Depression 18. tDCS for Treatment-Resistant Depression 19. ECT for Treatment-Resistant Depression 20. MST for Treatment-Resistant Depression 21. VNS for Treatment-Resistant Depression 22. Deep Brain Stimulation for Treatment-Resistant Depression 23. Other neurosurgical interventions for Treatment-Resistant Depression 24. Treatment-Resistant Psychotic Depression 25. Evidence-Based psychotherapy for Treatment-Resistant Depression 26. Treatment-Resistant Bipolar Depression 27. Treatment-Resistant Depression in Child and Adolescents 28. Treatment-Resistant Depression in Geriatrics 29. Identification and Management of Anxious Depression in Patients with Treatment-Resistant Depression 30. Managing Treatment-Resistant Depression with Comorbid Personality Disorders 31. Managing Treatment-Resistant Depression with Comorbid Substance Use Disorders 32. Managing Treatment-Resistant Depression in the setting of chronic pain 33. Inhaled Gases for Treatment-Resistant Major Depression 34. Drugs under investigation for Treatment-Resistant Depression 35. Chronotherapeutics for Treatment-Resistant Depression 36. Managing Treatment-Resistant Depression in Primary Care Settings 37. Treatment-Resistant Depression in Pregnancy, the Postpartum Period, and Transition to Menopause 38. Lifestyle Interventions for Treatment-Resistant Depression 39. Managing the Risk of Suicide in People with Treatment-Resistant Depression 40. Maintaining Motivation and Preserving the Therapeutic Alliance as tools to overcome Treatment-Resistant Depression
